Industry
Biotechnology
Topic
Investments
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Investments in Biotechnology
... Basel, Switzerland-based Therachon, a biotechnology company focused on rare diseases, has closed $60 million in ...
... Akouos , a precision genetic medicine company developing gene therapies that restore and ...
... Boston-based Akouos, a precision genetic medicine company, has raised $50 million in Series A ...
... Because music is important to him, Manny Simons, CEO of Akouos, says he may have a greater awareness of hearing loss. Manny Simons, ...
... and fantasy for these patients." (Fortune) INDICATIONS Regeneron pours $100 million into Bluebird. Regeneron Pharmaceuticals is making a huge bet on upstart biotech Bluebird Bio ...
... equity. Participants included ARCH Venture Partners, the Wellcome Trust, Steven Paul M.D., PureTech Health, and other undisclosed investors. Karuna plans to use the proceeds from ...
... Anderson Cancer Center in Houston. UCART19 and Corporate Collaboration In April, Allogene Therapeutics, Inc. ("Allogene"), a new biotechnology company co-founded by Dr. Arie Belldegrun and ...
... UK-based ReViral, an antiviral drug discovery and development company, has closed $55 million in ...
... UK-based Healx, a developer of treatments for rare diseases, has secured $10 million in ...
... HEALX, a Cambridge-based medical technology startup that uses artificial intelligence to find new ...
Subscribe now for full coverage on Investments in Biotechnology
Start My Free Trial